These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37124778)

  • 21. Does China's centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model.
    Gu Y; Zhuang Q
    Front Pharmacol; 2023; 14():1192423. PubMed ID: 37324496
    [No Abstract]   [Full Text] [Related]  

  • 22. How do carbon emissions trading impact the financialization of non-financial companies? Evidence from a quasi-natural experiment in China.
    Ma W; Yan X
    PLoS One; 2023; 18(12):e0296277. PubMed ID: 38150448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does green finance restrain corporate financialization?
    Zhou C; Qi S
    Environ Sci Pollut Res Int; 2023 Jun; 30(27):70661-70670. PubMed ID: 37155100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whether Green Finance Improves Green Innovation of Listed Companies-Evidence from China.
    Dong Z; Xu H; Zhang Z; Lyu Y; Lu Y; Duan H
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green finance and corporate environmental responsibility: evidence from heavily polluting listed enterprises in China.
    He L; Zhong T; Gan S
    Environ Sci Pollut Res Int; 2022 Oct; 29(49):74081-74096. PubMed ID: 35643997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do the Green Credit Guidelines Affect Corporate Green Technology Innovation? Empirical Research from China.
    Hong M; Li Z; Drakeford B
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33578645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon emission trading scheme and corporate labor investment efficiency: evidence from China.
    Ma J; Xiang Y; Bai X
    Environ Sci Pollut Res Int; 2023 Aug; 30(39):90830-90843. PubMed ID: 37462874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Does Green Innovation Strategy Influence Corporate Financing? Corporate Social Responsibility and Gender Diversity Play a Moderating Role.
    Javeed SA; Teh BH; Ong TS; Chong LL; Abd Rahim MFB; Latief R
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why do sports goods manufacturers choose different corporate social responsibility engagements?
    Guo Y; Kang D; Huang C; Chen Y
    PLoS One; 2023; 18(12):e0295682. PubMed ID: 38128059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of CEO Narcissism and Corporate R&D Investment.
    Wang L; Li H; Mu Y
    Front Psychol; 2022; 13():888618. PubMed ID: 35645881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supply chain concentration and enterprise financialization: Evidence from listed companies in China's manufacturing industry.
    He H; Zuo Z
    PLoS One; 2023; 18(5):e0285308. PubMed ID: 37163518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of digital finance on SMEs financialization: Evidence from thirty million Chinese enterprise registrations.
    Gao X; Ren Y
    Heliyon; 2023 Aug; 9(8):e18664. PubMed ID: 37560700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of technological innovation on corporate leverage in China: The moderating role of policy incentives and market competition.
    Ren L; Liu D; Xiong D
    Front Psychol; 2022; 13():1068375. PubMed ID: 36533031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State-owned capital and quality of green innovation: Evidence from Chinese listed private firms.
    Yan H; Chen Z; Yang Y
    Heliyon; 2024 Apr; 10(7):e28179. PubMed ID: 38560115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corporate social responsibility, financing constraints, and corporate carbon intensity: new evidence from listed Chinese companies.
    Chen P
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):40107-40115. PubMed ID: 36609966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Financing Constraints and Firm's Productivity Under the COVID-19 Epidemic Shock: Evidence of A-Shared Chinese Companies.
    Wong Z; Chen A; Taghizadeh-Hesary F; Li R; Kong Q
    Eur J Dev Res; 2023; 35(1):167-195. PubMed ID: 35194343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does digital finance promote corporate social responsibility of pollution-intensive industry? Evidence from Chinese listed companies.
    Xin D; Yi Y; Du J
    Environ Sci Pollut Res Int; 2022 Dec; 29(56):85143-85159. PubMed ID: 35790640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do environmental, social, and governance scores improve green innovation? Empirical evidence from Chinese-listed companies.
    Zhang C; Chen D
    PLoS One; 2023; 18(5):e0279220. PubMed ID: 37228130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. M&A goodwill and corporate technological innovation: The mediating moderating effect of stock pledges.
    Zhang Y; Sun Z; Zhou Y; Dong Y
    PLoS One; 2022; 17(8):e0271214. PubMed ID: 36037164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.